BCM
ABBV icon

Boreal Capital Management’s AbbVie ABBV Stock Holding History

Boreal Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$428K Buy
1,970
+1
+0.1% +$222 0.35% 72
2025
Q4 		$450K Hold
1,969
– – 0.34% 78
2025
Q3 		$456K Buy
1,969
+36
+2% +$7.33K 0.37% 77
2025
Q2 		$359K Buy
+1,933
New +$359K 0.3% 93

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boreal Capital Management's ABBV Position: Q1 2026 in Review

Boreal Capital Management increased its AbbVie (ABBV) stake by 0.05% in Q1 2026, buying an estimated $222 and bringing the position to 1,970 shares worth $428K. The position accounts for 0.35% of the portfolio, ranked #72.

Boreal Capital Management first reported a position in ABBV in Q2 2025 and has held it in 4 quarters since. The position peaked at $456K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Boreal Capital Management held 1,970 shares of AbbVie worth $428K as of Q1 2026.
  • Boreal Capital Management bought 1 AbbVie share in Q1 2026, an estimated $222.
  • AbbVie made up 0.35% of Boreal Capital Management's portfolio in Q1 2026, its #72 holding.
  • Boreal Capital Management first reported a position in AbbVie in Q2 2025 and has held it in 4 quarters since.
  • Boreal Capital Management's AbbVie position peaked at $456K in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Boreal Capital Management's 13F filing for Q1 2026, filed 14 May 2026.